The knee is the most susceptible joint in the human body to pressure and injury. Knees undergo complex interactions of rotational and extensional movements. The U.S. market for ACL/PCL reconstruction devices indicates growth at a single-digit CAGR over the forecast period to exceed $359 million by 2026. What are the ACL and PCL? ACL and
Did you know there are over 8.9 million orthopedic procedures performed in the United States each year, with the orthopedic biomaterials market showing the greatest forecast growth? As this market continues to grow and innovative technologies are being designed, we have compiled a list of the top companies within different categories of the orthopedics market including: Orthopedic
The U.S. Food and Drug Administration recently granted marketing authorization for an anterior cruciate ligament (ACL) implant, intended to perform as an alternative to traditional ACL reconstructions. The Bridge-Enhanced ACL Repair (BEAR) Implant, by Miach Orthopaedics, differs from the traditional surgical reconstruction as it does not require the use of harvested tendons for ACL repair
Engage Surgical has gained FDA approval for its Engage Partial Knee system, making it the only cementless partial knee system approved for use in the U.S. It uses Engage’s innovative Anchor technology to provide stability at the tibial surface, and increased compression compared to other techniques. The Engage Partial Knee system is also combined with
According to the latest study by iData Research, the U.S. sports medicine market was valued at $1.7 billion by 2020. The total market is highly limited by the relatively stable incidence rate of tendon and ligament injuries, which varies greatly among different anatomies and different population groups. In spite of this trend, the level of
Anika, an orthopedic device manufacturer based out of Bedford, Massachusetts, has announced the release of six new sports medicine products in 2020. This marks the first time Anika has released new products since acquiring Parcus Medical and Arthrosurface earlier in the year. All six of these products have received FDA approval. They are mainly focused
Interview with ATRO Medical CEO on Trammpolin® Meniscus ProsthesisMeniscal tears can happen from a sudden forceful impact or twisting of the knee, which frequently occurs in athletic injuries. Depending on the lesion type, size, vascularization and location, doctors can asses if the tear can be repaired by suturing, or if the damaged parts need to
A first in pediatric orthopedics, the FDA cleared OrthoPediatrics pediatric-specific system for treating foot deformities. The company has announced the launch of this system in the United States in November of 2019. Register to receive a free Small Bone and Joint Devices Market Analysis, Size, Trends Report synopsis and brochure. The PediFoot system utilizes smaller
Countries like Japan investing $3.67 billion in the Tokyo 2020 summer games are one of many factors increasing the awareness and importance of sports medicine. Knee-related injuries are one of the most common types in professional sports. What’s more, iData Research has found that athletes undergo ACL, PCL and meniscal surgical repairs every year more
Register to receive a free Global Sports Medicine Market Analysis, Size, Trends Report synopsis and brochure. Active Implants looks to create an alternative between minimally invasive meniscus and total knee replacement. Creating a new segment in meniscal surgery with meniscus replacement, their Nusurface Meniscus Implant has been granted breakthrough device designation by the FDA. Made
